EFFECTIVENESS OF THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EFFECTIVENESS OF THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hematological oncology 2021-06, Vol.39 (S2)
Hauptverfasser: Kogarko, I, Golenkov, A.K, Kataeva, E.V, Kogarko, B.S., Ganeev, I.I
Format: Artikel
Sprache:eng
Schlagworte:
Chronic lymphocytic leukemia
Cyclophosphamide
Fludarabine
Immunotherapy
Leukemia
Lymphatic leukemia
Monoclonal antibodies
Rituximab
Targeted cancer therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue S2
container_start_page
container_title Hematological oncology
container_volume 39
creator Kogarko, I
Golenkov, A.K
Kataeva, E.V
Kogarko, B.S.
Ganeev, I.I
description
doi_str_mv 10.1002/hon.19_2881
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2541698017</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2541698017</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1011-1c63b0ebe70e5053b16570f6e60a46b61bf3a1fbd96793091d72667c13aabf7d3</originalsourceid><addsrcrecordid>eNotkMtOg0AUhidGE2t15QtM4kaj1HOYMsByOh1kIoWGi9oVgRaijZYKduHGZ5emXZ0_Of8l-Qi5RhghgPn43mxG6Oam4-AJGSC4roHA3VMyANN2DDCZeU4uum4N0P_AGZA_5XlKpvpFhSpJaOTR1FexmC_oq0596gXZVMRiokP1QOVCBtHcj5K5L2Z6qqgIpzTWafamZ2JCbz0Z31EviulcpFqFaXLokH4chVrSYDHrw3KR7rXKntVMi0tyVhefXXV1vEOSeSqVvhFET1qKwFgiIBq45KyEqqxsqCywWIncsqHmFYdizEuOZc0KrMuVy22XgYsr2-TcXiIrirK2V2xIbg6927b53lXdT75udu2mn8xNa4zcdQDt3nV_cC3bpuvaqs637cdX0f7mCPkecN4Dzo-A2T8qpmNI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2541698017</pqid></control><display><type>article</type><title>EFFECTIVENESS OF THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kogarko, I ; Golenkov, A.K ; Kataeva, E.V ; Kogarko, B.S. ; Ganeev, I.I</creator><creatorcontrib>Kogarko, I ; Golenkov, A.K ; Kataeva, E.V ; Kogarko, B.S. ; Ganeev, I.I</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.19_2881</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Chronic lymphocytic leukemia ; Cyclophosphamide ; Fludarabine ; Immunotherapy ; Leukemia ; Lymphatic leukemia ; Monoclonal antibodies ; Rituximab ; Targeted cancer therapy</subject><ispartof>Hematological oncology, 2021-06, Vol.39 (S2)</ispartof><rights>2021 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Kogarko, I</creatorcontrib><creatorcontrib>Golenkov, A.K</creatorcontrib><creatorcontrib>Kataeva, E.V</creatorcontrib><creatorcontrib>Kogarko, B.S.</creatorcontrib><creatorcontrib>Ganeev, I.I</creatorcontrib><title>EFFECTIVENESS OF THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA</title><title>Hematological oncology</title><subject>Chronic lymphocytic leukemia</subject><subject>Cyclophosphamide</subject><subject>Fludarabine</subject><subject>Immunotherapy</subject><subject>Leukemia</subject><subject>Lymphatic leukemia</subject><subject>Monoclonal antibodies</subject><subject>Rituximab</subject><subject>Targeted cancer therapy</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotkMtOg0AUhidGE2t15QtM4kaj1HOYMsByOh1kIoWGi9oVgRaijZYKduHGZ5emXZ0_Of8l-Qi5RhghgPn43mxG6Oam4-AJGSC4roHA3VMyANN2DDCZeU4uum4N0P_AGZA_5XlKpvpFhSpJaOTR1FexmC_oq0596gXZVMRiokP1QOVCBtHcj5K5L2Z6qqgIpzTWafamZ2JCbz0Z31EviulcpFqFaXLokH4chVrSYDHrw3KR7rXKntVMi0tyVhefXXV1vEOSeSqVvhFET1qKwFgiIBq45KyEqqxsqCywWIncsqHmFYdizEuOZc0KrMuVy22XgYsr2-TcXiIrirK2V2xIbg6927b53lXdT75udu2mn8xNa4zcdQDt3nV_cC3bpuvaqs637cdX0f7mCPkecN4Dzo-A2T8qpmNI</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Kogarko, I</creator><creator>Golenkov, A.K</creator><creator>Kataeva, E.V</creator><creator>Kogarko, B.S.</creator><creator>Ganeev, I.I</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>202106</creationdate><title>EFFECTIVENESS OF THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA</title><author>Kogarko, I ; Golenkov, A.K ; Kataeva, E.V ; Kogarko, B.S. ; Ganeev, I.I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1011-1c63b0ebe70e5053b16570f6e60a46b61bf3a1fbd96793091d72667c13aabf7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Chronic lymphocytic leukemia</topic><topic>Cyclophosphamide</topic><topic>Fludarabine</topic><topic>Immunotherapy</topic><topic>Leukemia</topic><topic>Lymphatic leukemia</topic><topic>Monoclonal antibodies</topic><topic>Rituximab</topic><topic>Targeted cancer therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kogarko, I</creatorcontrib><creatorcontrib>Golenkov, A.K</creatorcontrib><creatorcontrib>Kataeva, E.V</creatorcontrib><creatorcontrib>Kogarko, B.S.</creatorcontrib><creatorcontrib>Ganeev, I.I</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kogarko, I</au><au>Golenkov, A.K</au><au>Kataeva, E.V</au><au>Kogarko, B.S.</au><au>Ganeev, I.I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EFFECTIVENESS OF THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA</atitle><jtitle>Hematological oncology</jtitle><date>2021-06</date><risdate>2021</risdate><volume>39</volume><issue>S2</issue><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.19_2881</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0278-0232
ispartof Hematological oncology, 2021-06, Vol.39 (S2)
issn 0278-0232
1099-1069
language eng
recordid cdi_proquest_journals_2541698017
source Wiley Online Library Journals Frontfile Complete
subjects Chronic lymphocytic leukemia
Cyclophosphamide
Fludarabine
Immunotherapy
Leukemia
Lymphatic leukemia
Monoclonal antibodies
Rituximab
Targeted cancer therapy
title EFFECTIVENESS OF THERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T10%3A27%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EFFECTIVENESS%20OF%20THERAPY%20WITH%20FLUDARABINE,%20CYCLOPHOSPHAMIDE%20AND%20RITUXIMAB%20(FCR)%20FOR%20PATIENTS%20WITH%20CHRONIC%20LYMPHOCYTIC%20LEUKEMIA&rft.jtitle=Hematological%20oncology&rft.au=Kogarko,%20I&rft.date=2021-06&rft.volume=39&rft.issue=S2&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.19_2881&rft_dat=%3Cproquest_cross%3E2541698017%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2541698017&rft_id=info:pmid/&rfr_iscdi=true